Page last updated: 2024-09-04

tipifarnib and epidermal growth factor

tipifarnib has been researched along with epidermal growth factor in 5 studies

Compound Research Comparison

Studies (tipifarnib)	Trials (tipifarnib)	Recent Studies (post-2010) (tipifarnib)	Studies (epidermal growth factor)	Trials (epidermal growth factor)	Recent Studies (post-2010) (epidermal growth factor)
309	92	94	24,155	217	4,699

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sánchez De Cos Escuín, J	1
Khuri, FR	1
Cornelissen, B; Dierckx, RA; Kersemans, V; Lahorte, C; Slegers, G; Thonissen, T; Van De Wiele, C	1
Abbruzzese, A; Budillon, A; Caraglia, M; Colao, A; D'Alessandro, AM; Giuberti, G; Marra, M; Prete, SD; Tagliaferri, P; Tassone, P; Venuta, S; Viscomi, C; Vitale, G	1
Boerman, O; Burvenich, I; Cornelissen, B; Kersemans, V; Oltenfreiter, R; Slegers, G; Vanderheyden, JL; Vandewiele, C	1

Reviews

2 review(s) available for tipifarnib and epidermal growth factor

Article	Year
[New therapeutic targets and strategies in lung cancer]. Archivos de bronconeumologia, 2002, Volume: 38, Issue:8 Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention. Clinical lung cancer, 2003, Volume: 5 Suppl 1 Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Clinical Trials as Topic; Disease Progression; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Precancerous Conditions; Protein-Tyrosine Kinases; Quinazolines; Quinolones	2003

Article

Year

[New therapeutic targets and strategies in lung cancer].

Archivos de bronconeumologia, 2002, Volume: 38, Issue:8

Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention.

Clinical lung cancer, 2003, Volume: 5 Suppl 1

Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Clinical Trials as Topic; Disease Progression; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Precancerous Conditions; Protein-Tyrosine Kinases; Quinazolines; Quinolones

2003

Other Studies

3 other study(ies) available for tipifarnib and epidermal growth factor

Article	Year
Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status. Nuclear medicine and biology, 2004, Volume: 31, Issue:6 Topics: Alkyl and Aryl Transferases; Animals; Cell Line; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Farnesyltranstransferase; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasm Transplantation; Quinolones; Radiopharmaceuticals; Regression Analysis; Tissue Distribution	2004
The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate. Oncogene, 2004, Sep-09, Volume: 23, Issue:41 Topics: Alkyl and Aryl Transferases; Apoptosis; Caspases; Cell Division; Diphosphonates; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; Farnesyltranstransferase; Humans; Imidazoles; KB Cells; Mitogen-Activated Protein Kinases; Pamidronate; Protein Prenylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinolones; Zoledronic Acid	2004
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor. Nuclear medicine communications, 2005, Volume: 26, Issue:2 Topics: Alkyl and Aryl Transferases; Animals; Biomarkers, Tumor; Cell Line, Tumor; Colonic Neoplasms; Epidermal Growth Factor; ErbB Receptors; Farnesyltranstransferase; Humans; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organotechnetium Compounds; Quinolones; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome	2005